These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 7492817)
1. [Positron-emission tomography: role of 18F-fluorodeoxyglucose (18FDG) imaging in oncology]. Lagrange JL; Maublant J; Darcourt J Bull Cancer; 1995 Aug; 82(8):611-22. PubMed ID: 7492817 [TBL] [Abstract][Full Text] [Related]
2. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862 [TBL] [Abstract][Full Text] [Related]
3. [(18F)-2-fluorodeoxyglucose PET. Prospects for secondary prevention of mouth cavity carcinoma]. Kunkel M; Kuffner HD; Reichert TE; Benz P; Förster GJ; Wagner W Mund Kiefer Gesichtschir; 2000 Mar; 4(2):105-10. PubMed ID: 10851884 [TBL] [Abstract][Full Text] [Related]
4. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195 [TBL] [Abstract][Full Text] [Related]
5. Role of FDG-PET/CT in follow-up of patients treated with resective gastric surgery for tumour. Graziosi L; Bugiantella W; Cavazzoni E; Cantarella F; Porcari M; Baffa N; Donini A Ann Ital Chir; 2011; 82(2):125-9. PubMed ID: 21682102 [TBL] [Abstract][Full Text] [Related]
6. Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma. Dancheva Z; Bochev P; Chaushev B; Yordanova T; Klisarova A Nucl Med Rev Cent East Eur; 2016; 19(1):22-7. PubMed ID: 26841376 [TBL] [Abstract][Full Text] [Related]
7. Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma. Rodriguez M Acta Radiol Suppl; 1998; 417():1-36. PubMed ID: 9645167 [TBL] [Abstract][Full Text] [Related]
8. Imaging metastatic testicular germ cell tumours with 18FDG positron emission tomography: prospects for detection and management. Wilson CB; Young HE; Ott RJ; Flower MA; Cronin BF; Pratt BE; McCready VR; Horwich A Eur J Nucl Med; 1995 Jun; 22(6):508-13. PubMed ID: 7556294 [TBL] [Abstract][Full Text] [Related]
9. [Experimental study on the effectiveness of PET tumor images for cancer diagnosis]. Yoshioka T; Takahashi H; Oikawa H; Kanamaru R Gan To Kagaku Ryoho; 1994 Feb; 21(3):369-73. PubMed ID: 8109993 [TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation? Jansson T; Westlin JE; Ahlström H; Lilja A; Långström B; Bergh J J Clin Oncol; 1995 Jun; 13(6):1470-7. PubMed ID: 7751894 [TBL] [Abstract][Full Text] [Related]
11. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging. Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613 [TBL] [Abstract][Full Text] [Related]
13. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1. Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062 [TBL] [Abstract][Full Text] [Related]
14. Interpretation variability of 18FDG-positron emission tomography studies in dementia. Hoffman JM; Hanson MW; Welsh KA; Earl N; Paine S; Delong D; Coleman RE Invest Radiol; 1996 Jun; 31(6):316-22. PubMed ID: 8761863 [TBL] [Abstract][Full Text] [Related]
15. PET for sarcomas other than gastrointestinal stromal tumors. Toner GC; Hicks RJ Oncologist; 2008; 13 Suppl 2():22-6. PubMed ID: 18434635 [TBL] [Abstract][Full Text] [Related]
16. Relation between tissue nature and (18F) fluorodeoxyglucose kinetics evaluated by dynamic positron emission tomography in human brain tumors. Yamaguchi T; Sasaki H; Ogawa T; Mineura K; Uemura K; Kanno I; Shishido F; Murakami M; Inugami A; Higano S Acta Radiol Suppl; 1986; 369():415-8. PubMed ID: 2980513 [TBL] [Abstract][Full Text] [Related]
17. [PET scan in general practice for diagnosis of breast carcinoma]. Ruhlmann J; Oehr P; Bender H; Kozak B; Willkomm P; Schräder M; Biersack HJ Acta Med Austriaca; 1997; 24(2):63-7. PubMed ID: 9273808 [TBL] [Abstract][Full Text] [Related]
18. Is positron emission tomography reliable to predict post-chemotherapy retroperitoneal lymph node involvement in advanced germ cell tumors of the testis? Akbulut Z; Canda AE; Atmaca AF; Caglayan A; Asil E; Balbay MD Urol J; 2011; 8(2):120-6. PubMed ID: 21656470 [TBL] [Abstract][Full Text] [Related]
19. Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer. Sun SS; Chen TC; Yen RF; Shen YY; Changlai SP; Kao A Anticancer Res; 2001; 21(4B):2957-61. PubMed ID: 11712793 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of 18FDG positron emission tomography in detection and follow-up of digestive cancers. Paulus P; Hustinx R; Daenen F; Jacquet N; Rigo P Acta Gastroenterol Belg; 1997; 60(4):278-80. PubMed ID: 9529672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]